Stock Analiz

Medicinova Inc. (MNOV) stock forecast and price target

Price $1.40 · data as of November 13, 2026

12-month price target

Average target$8.25
Upside / downside+491.4%
Analysts4
ConsensusNone
Low $6.00Average $8.25High $11.00

Gold marker: average target · white marker: today’s price ($1.40)

Analyst ratings

Strong buy 1Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.26−7.0%$730000
Next fiscal year
ends December 31, 2027
$-0.52−100.6%$333330
Next quarter
ends December 31, 2026
$-0.08−60.0%$33330
Quarter after
ends March 31, 2027
$-0.08−60.0%$0

Consensus of the analysts covering Medicinova, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Medicinova stock price target?

The average 12-month target from 4 analysts is $8.25, 491.4% above the current price of $1.40 Targets range from $6.00 to $11.00.

Is Medicinova a buy according to analysts?

The consensus rating is “None” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Medicinova expected to earn?

Analysts expect EPS of $-0.26 for the fiscal year ending December 31, 2026 and $-0.52 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.